Finding new treatments for bone cancer using patient-derived models
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
This work looks for new ways to treat osteosarcoma, a type of bone cancer, especially in children and young adults, by testing promising new medicines.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11121898 on NIH RePORTER |
What this research studies
For patients with osteosarcoma, current treatments haven't changed much in decades, making it hard to find new effective options. Our team is working to discover new targets in osteosarcoma by carefully studying patient-derived cancer cells and tissues. We then test potential new medicines against these targets in models that closely resemble human tumors. The goal is to find effective single agents or combinations that can move into clinical trials for patients.
Who could benefit from this research
Good fit: This foundational work is for patients with osteosarcoma, particularly children, adolescents, and young adults, whose tumors may provide insights for new therapies.
Not a fit: Patients without osteosarcoma or those whose cancer does not match the specific molecular targets being studied may not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective treatment options for children and young adults with osteosarcoma.
How similar studies have performed: Developing new therapies for osteosarcoma has been challenging, but this approach builds on existing methods of genomic profiling and preclinical testing to identify promising agents.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Gorlick, Richard G. — University of Tx Md Anderson Can Ctr
- Study coordinator: Gorlick, Richard G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.